Southern California Clinical and Translational Science Institute
SC CTSI is the joint USC-CHLA clinical and translational research institute that accelerates studies via eight specialized core groups, proprietary tools (Trial Tracker, Quality by Design Toolkit, Trial Promoter), and grant-funded training and pilot funding for academic and healthcare-delivery researchers.
- Company typePrivate
- Founded2008
- HeadquartersLos Angeles, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Southern California Clinical and Translational Science Institute does
SC CTSI is a joint research institute of the University of Southern California (USC) and Children's Hospital Los Angeles (CHLA), operating since 2008 to accelerate clinical and community-partnered translational research across Southern California. It is a member of the NIH-funded Clinical and Translational Science Awards (CTSA) consortium led by NCATS, functioning primarily as an academic research support center rather than a commercial enterprise. It serves a defined internal community of principal investigators, co-investigators, research staff, KL2 scholars, and community members at USC and CHLA, with adjacent services for healthcare delivery researchers (notably via LAC DHS) and broader consortium partners through the Trial Innovation Network.
The institute delivers its mission through eight specialized core groups spanning biostatistics and research design, clinical research informatics, clinical research support, community engagement, regulatory knowledge and support, research development, data science, workforce development, and dissemination and implementation. Its proprietary technology stack includes the Trial Tracker accrual dashboard (which pulls nightly from USC's OnCore CTMS), the Trial Promoter automated recruitment messaging tool, the Quality by Design (QbD) Toolkit, and the OpenRegSource Regulatory Portal. The SC CTSI Learning Network, built on Brightspace, hosts courses, webinars, and self-study modules; REDCap is offered as a core data capture resource with hands-on workshops. Integration across OnCore, REDCap, and the institute's internal tools provides connective tissue spanning study design, regulatory approval, recruitment, conduct, and dissemination.
Revenue mechanics are anchored in NIH/NCATS CTSA grant funding (notably UL1TR001855), supplemented by modest course fees (Behavioral Economics $160, Dissemination and Implementation $80, Health Systems Engineering $35) while the Clinical Trial Quality Training Series and most core services remain free-of-charge to eligible researchers. Pricing follows a freemium model underwritten by recurring grant inflows. Distribution is regional and direct: consultation services via specialized cores, self-service online tools, group training programs, and pilot funding distributed through institutional review processes at USC and CHLA, with no commercial sales channels.
Southern California Clinical and Translational Science Institute firmographics
Firmographics- Name
- Southern California Clinical and Translational Science Institute
- Legal name
- Southern California Clinical and Translational Science Institute
- Website
- https://sc-ctsi.org
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- SC CTSI is the joint USC-CHLA clinical and translational research institute that accelerates studies via eight specialized core groups, proprietary tools (Trial Tracker, Quality by Design Toolkit, Trial Promoter), and grant-funded training and pilot funding for academic and healthcare-delivery researchers.
- Ownership category
- akta.pro rank
Southern California Clinical and Translational Science Institute industry classification
Industry- Product category
- Clinical and Translational Research Support
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Educational Support Services (611710), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Educational Services (8200)
- akta.pro primary industry
- Investigator & Site Training / GCP Support (HLAGACAF)
- akta.pro secondary industries
- Clinical Trial Management Systems (CTMS) (HLACAOAD), Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ), KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)
Keywords
Where Southern California Clinical and Translational Science Institute is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Southern California Clinical and Translational Science Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- NIH CTSA Grant Funding: Primary funding from the National Center for Advancing Translational Science (NCATS) of the U.S. National Institutes of Health through the CTSA Program. All publications resulting from SC CTSI resources must credit the SC CTSI grant.
- Educational Course Fees: Some courses have associated fees including Health Systems Engineering ($35), Behavioral Economics ($160), and Dissemination and Implementation ($80). Many courses are provided free of charge.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Research tools and services provided at no cost |
| Freemium | Pay-as-you-go | Free educational offerings |
| Subscription | Pay-as-you-go | Health Systems Engineering course |
| Subscription | Pay-as-you-go | Behavioral Economics course |
| Subscription | Pay-as-you-go | Dissemination and Implementation course |
| Freemium | Pay-as-you-go | Clinical Trial Quality Training Series modules |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Southern California Clinical and Translational Science Institute product offering
Product offeringCore offering
SC CTSI provides clinical and translational research infrastructure, training, and consultative services to investigators at USC and affiliated institutions. Its offerings include clinical research support (study coordination, recruitment), biostatistics and bioinformatics consulting, regulatory/ethics guidance, community engagement, pilot funding programs, and informatics tools such as Trial Tracker, Trial Promoter, and the Quality by Design Toolkit.
Differentiator
Problem solved
Functional benefit
Products and services
- SC CTSI Learning Network
Quantifiable outcome
- Design Studios helped identify approximately 4 potential risks per study on average
- +1 more outcomes
Companies that use Southern California Clinical and Translational Science Institute
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles2 records
Southern California Clinical and Translational Science Institute technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature5 records
Southern California Clinical and Translational Science Institute partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- University of Southern California (USC)coreUSC is one of the two primary institutional partners of SC CTSI. The institute is headquartered at USC and provides research support services to USC investigators across all schools and departments. USC faculty and staff can access all SC CTSI resources including funding opportunities, training, and consultation services.
- Children's Hospital Los Angeles (CHLA)coreCHLA is the co-sponsoring institution of SC CTSI. The institute provides dedicated support for pediatric research at CHLA through specific programs like the CTSI Horizons program that facilitates collaboration between USC and CHLA investigators.
- NCATS/CTSA ConsortiumcoreSC CTSI is part of the National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Awards (CTSA) consortium, a national network of institutions working to accelerate clinical and translational research.
- DK Kim International Center for Regulatory SciencecoreA collaborative center within USC School of Pharmacy that partners with SC CTSI's Regulatory Knowledge & Support core to develop training modules on clinical trial quality, monitoring, auditing, and FDA site inspection readiness.
- LA County Department of Health Services (LAC DHS)coreLAC DHS partners with SC CTSI in supporting research designed to enhance quality, efficiency, and patient-centeredness of care. This includes the Healthcare Delivery Science program which fosters professional development of clinician-investigators working in LAC DHS.
- California Institute for Regenerative Medicine (CIRM)minorCIRM provides funding through the USC+CHLA Alpha Clinic for the Cell and Gene Therapy Trials course development, supporting training in regenerative medicine clinical trials.
- Clinical Trial Transformation Initiative (CTTI)minorSC CTSI's Quality by Design program aligns with CTTI's quality framework, contributing to a community of practice for quality by design in clinical research.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Southern California Clinical and Translational Science Institute competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Southern California Clinical and Translational Science Institute social profiles
Digital presenceSouthern California Clinical and Translational Science Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Southern California Clinical and Translational Science Institute leadership team
Management profileNumber of profiles
Profiles10 records
Southern California Clinical and Translational Science Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Southern California Clinical and Translational Science Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Southern California Clinical and Translational Science Institute
What does Southern California Clinical and Translational Science Institute do?
SC CTSI provides clinical and translational research infrastructure, training, and consultative services to investigators at USC and affiliated institutions. Its offerings include clinical research support (study coordination, recruitment), biostatistics and bioinformatics consulting, regulatory/ethics guidance, community engagement, pilot funding programs, and informatics tools such as Trial Tracker, Trial Promoter, and the Quality by Design Toolkit.
Is Southern California Clinical and Translational Science Institute a public or private company?
Southern California Clinical and Translational Science Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Southern California Clinical and Translational Science Institute founded?
Southern California Clinical and Translational Science Institute was founded in 2008. It employs 101 to 250 people.
Where is Southern California Clinical and Translational Science Institute based?
Southern California Clinical and Translational Science Institute is headquartered in Los Angeles, United States, in the North America region.
How does Southern California Clinical and Translational Science Institute make money?
Two revenue lines are on record. NIH CTSA Grant Funding is the primary driver. The others are educational Course Fees.
Does Southern California Clinical and Translational Science Institute have an API?
No public API is recorded for Southern California Clinical and Translational Science Institute.
What industry is Southern California Clinical and Translational Science Institute in?
Southern California Clinical and Translational Science Institute's product category is Clinical and Translational Research Support. Its primary akta.pro industry code is HLAGACAF, Investigator & Site Training / GCP Support, with a secondary code of HLACAOAD, Clinical Trial Management Systems (CTMS). Its NAICS code is 54171 and its SIC code is 8731.